Caliper Taps Invitrogen Alumnus as CCO; NCRR Names New Director; Archemix, BioTrove, and Alnylam Flesh Out Boards; and Others | GenomeWeb
An earlier version of this installment incorrectly reported that Caliper hired John DelliSanti to the posts of executive vice president and chief operating officer. In fact, he was hired as executive vice president and chief commercial officer.
 
NEW YORK (GenomeWeb News) — Caliper Life Sciences has named John DelliSanti to the posts of executive vice president and chief commercial officer. In the job, DelliSanti will oversee the company’s worldwide sales, marketing, and services functions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.